Skip to main content
SpringerLink
Log in

Prospective therapeutic studies in nephrolithiasis

  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Prospective randomized trials with respect to stone prophylaxis deal mainly with idiopathic calcium stone disease. There is a lot of evidence that alkali citrate, thiazides and allopurinol are effective in many patients. However, appropriate patient selection seems to be crucial. Alkali citrate and allopurinol have proven clinical efficacy in patients with hypocitraturia or hyperuricosuria, respectively. The correct method of patient selection for treatment with thiazides remains unclear. Despite the lack of prospective randomized trials, it is generally accepted that the first steps in the prophylaxis of idiopathic calcium stone disease are high fluid intake and a sensible diet.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ackermann DK (1990) Prophylaxis in idiopathic calcium urolithiasis. Urol Res 18 [Suppl 1]: 37–40

    Google Scholar 

  2. Ackermann DK (1996) Metaphylaxis of organic stones. In: Bichler KH, Strohmaier WL, Wilbert DM, Mattauch W (eds) Urolithiasis. Attempto, Tübingen, pp 61–72

    Google Scholar 

  3. Ala-Opas M, Elomaa I, Porkka L, Alfthan O (1987) Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stones. Scand J Urol Nephrol 21: 311–314

    Google Scholar 

  4. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CYC (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150: 1761–1764

    Google Scholar 

  5. Brocks P, Dahl C, Wolf H, Transbol I (1981) Do thiazides prevent recurrent idiopathic calcium stones? Lancet 11: 124–125

    Google Scholar 

  6. Butz M, Schwab G (1990) Alkalicitrate versus diet: a randomized long-term trial in recurrent calcium stone formers. In: Vahlensieck W, Gasser G, Hesse A, Schoeneich G (eds) Proceedings of the 1st European Symposium on Urolithiasis. Excerpta Medica, Amsterdam Hong Kong Princeton, pp 184–187

    Google Scholar 

  7. Churchill DN (1987) Medical treatment to prevent recurrent calcium urolithiasis. Miner Electrolyte Metab 13: 294–304

    Google Scholar 

  8. Churchill DN, Taylor DW (1985) Thiazides for patients with recurrent calcium stones: still an open question. J Urol 133: 749–751

    Google Scholar 

  9. Cicerello E, Merlo F, Gambaro G, Maccatrozzo L, Fandella A, Baggio B, Anselmo G (1994) Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients. J Urol 151: 5–9

    Google Scholar 

  10. Curhan GC, Willett WC, Rimm EB, Stampfer MJ (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328: 833–838

    Google Scholar 

  11. Ettinger B (1976) Recurrent nephrolithiasis: natural history and effect of phosphate therapy. Am J Med 61: 200–206

    Google Scholar 

  12. Ettinger B, Tang A, Citron JT, Livermore B, Williams T (1986) Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315: 1386–1389

    Google Scholar 

  13. Ettinger B, Citron JT, Livermore B, Domant LI (1988) Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139: 679–684

    Google Scholar 

  14. Goldfarb S (1988) Dietary factors in the pathogenesis and prophylaxis of calcium nephrolithiasis. Kidney Int 34: 544–555

    Google Scholar 

  15. Hess B (1990) Prophylaxis of infection-induced kidney stone formation. Urol Res 18 [Suppl 1]: 45–48

    Google Scholar 

  16. Hofbauer J, Höbarth K, Szabo N, Marberger M (1994) Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis — a prospective randomized study. Br J Urol 73: 362–365

    Google Scholar 

  17. Hosking DH, Erickson SB, Berg CJ von den, Wilson DM, Smith LH (1983) The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 130: 1115–1118

    Google Scholar 

  18. Laerum E, Larsen S (1985) Thiazide prophylaxis of urolithiasis: a double blind study in general practice. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York London, pp 475–478

    Google Scholar 

  19. Ljunghall S (1985) Incidence of renal stones in Western countries. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York London, pp 31–37

    Google Scholar 

  20. Marks RG (1982) Designing a research project. Van Nostrand Reinhold, New York

    Google Scholar 

  21. Miano L, Petta S, Paradiso Galatioto G, Goldoni S, Tubaro A (1985) A placebo controlled double-blind study of allopurinol in severe recurrent idiopathic renal lithiasis. Preliminary results. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York London, pp 521–524

    Google Scholar 

  22. Mortensen JT, Schultz A, Ostergaard AH (1986) Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones. Int Urol Nephrol 18: 265–269

    Google Scholar 

  23. Ohkawa M, Tokunaga S, Nakashima T, Orito M, Hisazumi H (1992) Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol 69: 571–576

    Google Scholar 

  24. Parivar F, Low RK, Stoller ML (1996) The influence of diet on urinary stone disease. J Urol 155: 432–440

    Google Scholar 

  25. Robertson WG, Peacock M, Selby PL, Williams RE, Clark P, Chisholm GD, Hargreaves TB, Rose MB, Wilkinson H (1985) A multicentre trial to evaluate three treatments for recurrent idiopathic calcium stone disease — a preliminary report. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York London, pp 545–548

    Google Scholar 

  26. Scholz D, Schwille PO, Sigel A (1982) Double-blind study with thiazide in recurrent calcium lithiasis. J Urol 128: 903–907

    Google Scholar 

  27. Smith MJV (1977) Placebo versus allopurinol for renal calculi. J Urol 117: 690–692

    Google Scholar 

  28. Thomas WC (1978) Use of phosphates in patients with calcareous renal calculi. Kidney Int 13: 390–396

    Google Scholar 

  29. Williams JJ, Rodman JS, Peterson CM (1984) A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N Engl J Med 311: 760–764

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Kantonsspital, CH-9007, St. Gallen, Switzerland

    D. K. Ackermann

Authors
  1. D. K. Ackermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ackermann, D.K. Prospective therapeutic studies in nephrolithiasis. World J Urol 15, 172–175 (1997). https://doi.org/10.1007/BF02201854

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02201854

Keywords

Search

Navigation